Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D3020
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 2,139 $14,421,693 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $14,421,693 Current and potential, with all options
- Last date to order 84% complete
- IDV ceiling 1% used
- $999,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award is a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The single-award IDC, valued at $999,999,999, was awarded to Amerisourcebergen Drug Corp for a base period of 30 months and three 30-month option periods, with a total estimated value of $30.3 billion. The contract aims to establish Prime Vendor Contracts for the PPV-G program, which provides worldwide pharmaceutical support to the Defense Health Agency (DHA), Department of Defense (DoD) customers, the United States Coast Guard, Designated Providers, Other Government Agencies, and the US Naval Fleet, including the Hospital Ships USNS Mercy and USNS Comfort. The contract covers a comprehensive range of pharmaceutical products, including brand-name, generic, and specialty medications, as well as related medical supplies such as syringes, vials, and test kits, across multiple therapeutic areas. The contract is an unrestricted, fully competitive acquisition using a Lowest Price Technically Acceptable (LPTA) evaluation, with the potential for a reverse auction to obtain the best distribution fees for the primary supplier(s).
The original solicitation was for a pre-solicitation announcement, indicating the DLA Troop Support Medical Supply Chain's intention to issue a solicitation for the PPV-G GEN V program. The solicitation is expected to be issued in March 2024 and remain open for 45 days, with a vendor pre-proposal conference scheduled prior to the closing date. The contract will have a 30-month base period and three 30-month option periods, with the intention to make multiple awards for separate regions, including North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet (CONUS/OCONUS), as well as a separate award for a back-up supplier.
Task orders
Show 40 more
Latest 50 of 2,139 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D3020?
SPE2DR25D3020 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR25D3020 worth?
Orders under SPE2DR25D3020 have obligated $14,421,693. SPE2DR25D3020's own ceiling is $999,999,999.
How many orders have been placed under contract SPE2DR25D3020?
2,139 orders have been placed under SPE2DR25D3020, the latest on July 27, 2026.
Who can order from contract SPE2DR25D3020?
SPE2DR25D3020 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D3020 competed?
The extent of competition for SPE2DR25D3020 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV